4//SEC Filing
EnteroMedics Inc 4
Accession 0001209191-17-009595
CIK 0001371217operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:50 PM ET
Size
12.1 KB
Accession
0001209191-17-009595
Insider Transaction Report
Form 4
EnteroMedics IncETRM
McDougal Lori Courtney
Director
Transactions
- Award
Director Option (Right to Buy)
2017-02-08+30,000→ 30,000 totalExercise: $7.12From: 2017-02-08Exp: 2027-02-08→ Common Stock (30,000 underlying)
Holdings
- 0
Common Stock
- 23
Director Option (Right to Buy)
Exercise: $325.50Exp: 2025-07-31→ Common Stock (23 underlying) - 42
Director Option (Right to Buy)
Exercise: $52.50From: 2016-05-04Exp: 2026-05-04→ Common Stock (42 underlying)
Footnotes (3)
- [F1]On December 27, 2016, EnteroMedics Inc. effected a 1-for-70 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
- [F2]25% of the shares subject to the option are exercisable immediately. The remaining 75% of the shares subject to the option shall vest in a series of thirty-six (36) successive equal monthly installments upon completion of each month beginning on August 31, 2015 and ending on July 31, 2018.
- [F3]Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.
Issuer
EnteroMedics Inc
CIK 0001371217
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001371217
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:50 PM ET
- Size
- 12.1 KB